Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes

door Lin, Hung-Hsin, Lin, Jen-Kou, Jiang, Jeng-Kai, Lin, Chun-Chi, Lan, Yuan-Tzu, Yang, Shung-Haur, Wang, Huann-Sheng, Chen, Wei-Shone, Lin, Tzu-Chen, Liang, Wen-Yih, Chang, Shih-Ching
Gepubliceerd in World J Surg Oncol (2014)

Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection

door Chang, Chu-Cheng, Lan, Yuan-Tzu, Jiang, Jeng-Kai, Chang, Shih-Ching, Yang, Shung-Haur, Lin, Chun-Chi, Lin, Hung-Hsin, Wang, Huann-Sheng, Chen, Wei-Shone, Lin, Tzu-Chen, Lin, Jen-Kou
Gepubliceerd in World J Surg Oncol (2019)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery

door Yang, Kai-Lin, Yang, Shung-Haur, Liang, Wen-Yih, Kuo, Ying-Ju, Lin, Jen-Kou, Lin, Tzu-Chen, Chen, Wei-Shone, Jiang, Jeng-Kae, Wang, Huann-Sheng, Chang, Shih-Ching, Chu, Lee-Shing, Wang, Ling-Wei
Gepubliceerd in 2013

Building personalized treatment plans for early-stage colorectal cancer patients

door Lin, Hung-Hsin, Wei, Nien-Chih, Chou, Teh-Ying, Lin, Chun-Chi, Lan, Yuan-Tsu, Chang, Shin-Ching, Wang, Huann-Sheng, Yang, Shung-Haur, Chen, Wei-Shone, Lin, Tzu-Chen, Lin, Jen-Kou, Jiang, Jeng-Kai
Gepubliceerd in Oncotarget (2017)

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients

door Lu, Chieh-Sheng, Lin, Jen-Kou, Chen, Wei-Shone, Lin, Tzu-Chen, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Teng, Hao-Wei
Gepubliceerd in Oncotarget (2016)

Differences in gene mutations according to gender among patients with colorectal cancer

door Tsai, Yi-Jian, Huang, Sheng-Chieh, Lin, Hung-Hsin, Lin, Chun-Chi, Lan, Yuan-Tzu, Wang, Huann-Sheng, Yang, Shung-Haur, Jiang, Jeng-Kai, Chen, Wei-Shone, Lin, Tzu-chen, Lin, Jen-Kou, Chang, Shih-Ching
Gepubliceerd in World J Surg Oncol (2018)

Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread

door Hsu, Hung-Chih, Huang, Kuo-Cheng, Chen, Wei-Shone, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Huang, Sheng-Chieh, Cheng, Hou-Hsuan, Yang, Tsai-Sheng, Chen, Chien-Chih, Chao, Yee, Teng, Hao-Wei
Gepubliceerd in Sci Rep (2021)

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second...

door Lee, Yu-Ting, Liu, Chia-Jen, Hu, Yu-Wen, Teng, Chung-Jen, Tzeng, Cheng-Hwai, Yeh, Chiu-Mei, Chen, Tzeng-Ji, Lin, Jen-Kou, Lin, Chun-Chi, Lan, Yuan-Tzu, Wang, Huann-Sheng, Yang, Shung-Haur, Jiang, Jeng-Kai, Chen, Wei-Shone, Lin, Tzu-Chen, Chang, Shih-Ching, Chen, Ming-Huang, Teng, Hao-Wei, Liu, Jin-Hwang, Yen, Chueh-Chuan
Gepubliceerd in Medicine (Baltimore) (2015)